Drug Profile

AXN 1501

Alternative Names: AXN-1501

Latest Information Update: 04 Aug 2023

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

10 Jul 2023 Early research in Alzheimer's disease in South Korea prior to July 2023 (Axceso biopharma pipeline, July 2023)
11 May 2021 Axceso Biopharma has patent protection for Immunity enhancer containing phytosphingosine-1-phosphate or a derivative thereof use as a pharmaceutical composition for the treatment of dementia in USA
21 Mar 2018 Axceso Biopharma has patent protection for Use of phytosphingosine-1-phosphate or its derivatives for prevention or treatment of dementia in South Korea (Axceso biopharma website, July 2023)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com